ENZN
|Enzon Pharmaceuticals Inc
OTCQX
USD 0.10
-0.01|-5.45%
Current Price
USD 0.10
Change
USD -0.01 (-5.45%)
P/E Ratio
Dividend Yield
Market Cap
5.94M
Volume
500
Open
USD 0.10
Previous Close
USD 0.11
52-Week High
USD 0.24
52-Week Low
USD 0.07
About Enzon Pharmaceuticals Inc
Enzon Pharmaceuticals, Inc. does not have significant operations. Previously, it was engaged in the sale of its patented drug product, PegIntron. The company was formerly known as Enzon, Inc and changed its name to Enzon Pharmaceuticals, Inc. in December 2002. Enzon Pharmaceuticals, Inc. was incorporated in 1981 and is headquartered in Cranford, New Jersey.
Sector:Healthcare
Industry:Biotechnology
CEO:Mr. Richard L. Feinstein CPA
Employees:
Headquarters:Cranford, USA
Website:enzon.com
Dividend History
Dividend Payments
| Declared Date | Record Date | Payment Date | Amount | Frequency |
|---|
Similar Companies
Explore Stocks by Sector
technology
finance
healthcare
Frequently Asked Questions